The Japanese Generic Pharmaceutical Manufacturers Association (JGPMA), which includes forty pharmaceutical companies, has published a list comparing the effectiveness of generic drugs produced by its members to the corresponding medicines. This is primarily to inform and reassure the public, which seems to feel some confidence in generics, as was shown [...]
Researchers at the Hadassah Hospital in Jerusalem have found a way to slow the onset of symptoms caused by multiple sclerosis. These are promising “stem cells” that have this beneficial effect.
The team, led by Professor Tamir Ben Hur, director of Neurology and Professor Benjamin Reubinoff, director of research on human embryonic [...]
Some diseases such as tuberculosis, may remain dormant for years before causing further damage in the body. The fault lies with bacteria resistant to antibiotics. Researchers at the Hebrew University in Jerusalem just find ways to combat these bacteria.
Resistant bacteria, also known as dormant bacteria, do not suffer the work [...]
In late August, during the 12th Congress of the European Federation of Neurological Societies in Madrid, the Israeli company Teva has succeeded in presenting the results of clinical trials of Azilect. This new medicine, dedicated to patients with Parkinson’s disease shows promising results.
Olivier Rascol, a member of the department of clinical [...]